Frequency News and Research

RSS

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

Researchers explore the impact of differential immune imprinting patterns in individuals vaccinated against COVID-19 with a history of prior infection.

25 Jul 2022

SARS-CoV-2 seropositivity declines over seven months in healthy young adults

Researchers report the depletion of SARS-CoV-2 seropositivity in healthy young adults over a seven-month period.

25 Jul 2022

Long-COVID is relatively infrequent, but still poses a threat

A new study suggests that long COVID complaints may not be common among COVID-19 patients as compared to the general population.

25 Jul 2022

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Black patients have a dramatically higher risk of advanced vision loss after a new diagnosis of primary open angle glaucoma (POAG) when compared to white patients, according to a new study from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

25 Jul 2022

Wireless biochemical sensor may use biomarkers in sweat to detect changes in a person's health

Researchers have successfully tested a device that may one day use the chemical biomarkers in sweat to detect changes in a person's health.

22 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 21 Jul 2022

Parents become drug developers to save their children’s lives

Maggie Carmichael wasn't developing like other kids. As a toddler, she wasn't walking and had a limited vocabulary for her age.

21 Jul 2022

Scientists provide first report from the largest whole genome sequencing effort to date

Scientists at deCODE genetics a subsidiary of Amgen together with collaborators from Denmark report on the whole genome sequences of 150 thousand participants in the UK biobank in a paper published in the journal Nature today.

20 Jul 2022

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

Researchers reported mutations in SARS-CoV-2 Delta and Omicron variants of concern infection cases treated with neutralizing monoclonal antibodies.

20 Jul 2022

Genital dissatisfaction more prevalent in general population than expected according to new Swedish survey

A new study depicted that the genital self-image and satisfaction with one’s genitalia were generally low among Swedish men and women and genital size was not the only influencing factor for self-impression.

20 Jul 2022

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Researchers described the shedding of the monkeypox (MPX) virus (MPXV) in Barcelona city of Spain.

20 Jul 2022

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

A new study has pointed out that Molnupiravir treatment increases the ratio of transition to transversion mutations in COVID-19 patients and that the treatment does not appear to induce resistance mutations in the SARS-CoV-2 genome.

19 Jul 2022

Researchers report genomic profiling from more than 110,000 tumors

Researchers analyzed data from the latest public release of the GENIE project of the American Association for Cancer Research.

19 Jul 2022

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

AbbVie today announced it has submitted a marketing authorization application to the European Medicines Agency for atogepant for the prophylaxis of migraine in adult patients who have at least four migraine days per month.

From AbbVie 19 Jul 2022

Rice researchers use deactivated Cas9 proteins to synthetically trigger the transcription of genes

Rice University researchers have demonstrated that CRISPR-Cas9, increasingly famous as a gene-editing tool, can be employed in powerful additional ways in human cells.

18 Jul 2022

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Adding immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows it can reduce this risk of organ rejection and eliminate cancer in a quarter of patients.

18 Jul 2022

Frequency News and Research

Researchers report ‘hybrid immune damping’ following SARS-CoV-2 Omicron infection

SARS-CoV-2 seropositivity declines over seven months in healthy young adults

Long-COVID is relatively infrequent, but still poses a threat

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Wireless biochemical sensor may use biomarkers in sweat to detect changes in a person's health

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Parents become drug developers to save their children’s lives

Scientists provide first report from the largest whole genome sequencing effort to date

Researchers report the detection of viral mutations associated with drug resistance in patients treated with REGEN-COV and sotrovimab

Genital dissatisfaction more prevalent in general population than expected according to new Swedish survey

Researchers describe viral shedding of monkeypox virus in patients to better understand the possible role of different bodily fluids in disease transmission

Molnupiravir does not induce resistance mutations in SARS-CoV-2 genome

Researchers report genomic profiling from more than 110,000 tumors

AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine

Rice researchers use deactivated Cas9 proteins to synthetically trigger the transcription of genes

Anti-rejection drug plus immunotherapy could change the lives of kidney transplant patients with cancer

Decline in mental health during pregnancy throughout the COVID-19 lockdown period

Caregivers for patients with multiple myeloma may suffer from anxiety and depression

What is the impact of lower COVID-19 vaccine doses in younger cohorts?

How effective is previous infection in preventing reinfection with Omicron BA.4/BA.5?

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News